View our list of available Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) antibodies, recombinant proteins, ELISA Kits... Options Full Datasheet Printer Friendly Datasheet Prepare for Printing Full Datasheet Printer Friendly Datasheet Prepare for Printing Have Questions? Ask Us! Add To Compare List RESPIRATORY SYNCYTIAL VIRUS Antigen Catalog # MBS239141 Unit / Price DISCONTINUEDYou will be redirected to our replacement product Product Name Product Info Accession #s Product Desc Diseases/Tissues/Pathways Applications References Product Name RESPIRATORY SYNCYTIAL VIRUS, Antigen Popular Item Full Product Name NATIVE RESPIRATORY SYNCYTIAL VIRUS Research Use Only For Research Use Only. Not for use in diagnostic procedures. TOP Form/Format Inactivated PathogenInactivated Respiratory syncytial virus - liquid Concentration Total protein concentration 10.48 mg/ml (lot specific) Source Respiratory syncytial virus, Long strain, cultured in BSC-1 cells.Preparation Buffer Solution Culture medium 1969B Activity Native respiratory syncytial virus has been rendered inactive by standard procedures. However this material should still be handled as infectious and should be disposed of appropriately. Target Species Viral Preparation and Storage Store at -70 degree C. Storage in frost-free freezers is not recommended. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein.Shelf Life: 18 months from date of despatch. Other Notes Small volumes of RESPIRATORY SYNCYTIAL VIRUS antigen vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply. TOP Related Product Information for RESPIRATORY SYNCYTIAL VIRUS antigen Respiratory syncytial virus (RSV) is a member of the paramoxyvirus subfamily Pneumovirinae. RSV is a common cause of common cold-like respiratory tract illnesses, such as bronchiolitis and pneumonia, particularly in infants and young children. Most children will have been infected by the virus by 2-3 years of age. Infection does not confer immunity and re-infection is common. Currently no vaccine exists and treatment is mostly supportive. Native respiratory syncytial virus contains a high concentration of virus and viral components as well as some cellular material suspended in 1969B. Applications Tested/Suitable for RESPIRATORY SYNCYTIAL VIRUS antigen ELISA (EIA) TOP Precautions All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines. Disclaimer While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information. TOP